The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Antibodies against Vascular Endothelial Growth Factor Improve Early Renal Dysfunction in Experimental Diabetes
Abstract
: Vascular endothelial growth factor (VEGF) is a cytokine that potently stimulates angiogenesis, microvascular hyperpermeability, and endothelium-dependent vasodilation, effects that are largely mediated by endothelial nitric oxide synthase (eNOS). The expression of VEGF is pronounced in glomerular visceral epithelial cells, but its function in renal physiology and pathophysiology is unknown. VEGF expression is upregulated by high ambient glucose concentrations in several cell types in vitro and in glomeruli of diabetic rats. To assess the role of VEGF in the pathophysiology of early renal dysfunction in diabetes, monoclonal anti-VEGF antibodies (Ab) were administered to control and streptozotocin-induced diabetic rats for 6 wk after induction of diabetes. Based on in vitro binding studies, an adequate serum VEGF inhibitory activity was achieved during the entire course of anti-VEGF Ab administration. Anti-VEGF Ab treatment but not administration of isotype-matched control Ab decreased hyperfiltration, albuminuria, and glomerular hypertrophy in diabetic rats. VEGF blockade also prevented the upregulation of eNOS expression in glomerular capillary endothelial cells of diabetic rats. Antagonism of VEGF had no effect on GFR and glomerular volume in control rats. These results identify VEGF as a pathogenetic link between hyperglycemia and early renal dysfunction in diabetes. Targeting VEGF may prove useful as a therapeutic strategy for the treatment of early diabetic nephropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stereological Methods. Practical methods for biological morphometry
Weibel, E. R. (1979) · Academic Press eBooks · Cited by 1,994
Practical methods for biological morphometry
Weibel, E. R. (1979) · Academic Press eBooks · Cited by 1,563
Houck, K. A., Leung, D. W., Rowland, A. M., Winer, J., & Ferrara, N. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35712-0 · Cited by 1,127
Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor
Ishii, H., Jirousek, M. R., Koya, D., Takagi, C., Xia, P., Clermont, A., Bursell, S.-E., Kern, T. S., Ballas, L. M., Heath, W. F., et al. (1996) · Science · doi:10.1126/science.272.5262.728 · Cited by 1,103
Ziche, M., Morbidelli, L., Choudhuri, R., Zhang, H. T., Donnini, S., Granger, H. J., & Bicknell, R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119451 · Cited by 915
Ziyadeh, F. N., Hoffman, B. B., Han, D. C., Iglesias-de la Cruz, M. C., Hong, S. W., Isono, M., Chen, S., McGowan, T. A., & Sharma, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120055097 · Cited by 907
Role of vascular endothelial growth factor in the regulation of angiogenesis
Ferrara, N. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00610.x · Cited by 731
VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells
Hood, J. D., Meininger, C. J., Ziche, M., & Granger, H. J. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.274.3.h1054 · Cited by 699
Pertovaara, L., Kaipainen, A., Mustonen, T., Orpana, A., Ferrara, N., Saksela, O., & Alitalo, K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37365-9 · Cited by 694
Vascular Endothelial Growth Factor Induces Endothelial Fenestrations In Vitro
Esser, S., Wolburg, K., Wolburg, H., Breier, G., Kurzchalia, T., & Risau, W. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.4.947 · Cited by 648
Sharma, K., & Ziyadeh, F. N. (1995) · Diabetes · doi:10.2337/diab.44.10.1139 · Cited by 554
Cooper, M. E., Vranes, D., Youssef, S., Stacker, S. A., Cox, A. J., Rizkalla, B., Casley, D. J., Bach, L. A., Kelly, D. J., & Gilbert, R. E. (1999) · Diabetes · doi:10.2337/diabetes.48.11.2229 · Cited by 474
Advanced glycation end products increase retinal vascular endothelial growth factor expression.
Lu, M., Kuroki, M., Amano, S., Tolentino, M., Keough, K., Kim, I., Bucala, R., & Adamis, A. P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1277 · Cited by 423
Kuroki, M., Voest, E. E., Amano, S., Beerepoot, L. V., Takashima, S., Tolentino, M., Kim, R. Y., Rohan, R. M., Colby, K. A., Yeo, K. T., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118962 · Cited by 423
Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox.
Duh, E., & Aiello, L. P. (1999) · Diabetes · doi:10.2337/diabetes.48.10.1899 · Cited by 319
Williams, B., Gallacher, B., Patel, H., & Orme, C. (1997) · Diabetes · doi:10.2337/diab.46.9.1497 · Cited by 295
VEGF165 mediates glomerular endothelial repair
Ostendorf, T., Kunter, U., Eitner, F., Loos, A., Regele, H., Kerjaschki, D., Henninger, D. D., Janjic, N., & Floege, J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6740 · Cited by 287
Vascular permeability factor mRNA and protein expression in human kidney
Brown, L. F., Berse, B., Tognazzi, K., Manseau, E. J., Van De Water, L., Senger, D. R., Dvorak, H. F., & Rosen, S. (1992) · Kidney International · doi:10.1038/ki.1992.441 · Cited by 267
Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol.
Koya, D., Lee, I. K., Ishii, H., Kanoh, H., & King, G. L. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v83426 · Cited by 218
Tsuchida, K., Makita, Z., Yamagishi, S., Atsumi, T., Miyoshi, H., Obara, S., Ishida, M., Ishikawa, S., Yasumura, K., & Koike, T. (1999) · Diabetologia · doi:10.1007/s001250051198 · Cited by 215
Tilton, R. G., Kawamura, T., Chang, K. C., Ido, Y., Bjercke, R. J., Stephan, C. C., Brock, T. A., & Williamson, J. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119392 · Cited by 190
Self-citationNitric Oxide Synthase Isoforms and Glomerular Hyperfiltration in Early Diabetic Nephropathy
VEELKEN, R., HILGERS, K. F., HARTNER, A., HAAS, A., BO[Combining Diaeresis]HMER, K. P., & STERZEL, R. B. (2000) · Journal of the American Society of Nephrology · doi:10.1681/asn.v11171 · Cited by 181
Vascular endothelial growth factor and its receptors in control and diabetic rat eyes.
Gilbert, R. E., Vranes, D., Wilkinson‐Berka, J. L., Kelly, D. J., Cox, A. J., Wu, L. L., Stacker, S. A., & Cooper, M. E. (1998) · PubMed · Cited by 179
Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF.
Tilton, R. G., Chang, K. C., LeJeune, W. S., et al. (1999) · PubMed · Cited by 161
Self-citationSugimoto, H., Shikata, K., Matsuda, M., Kushiro, M., Hayashi, Y., Hiragushi, K., Wada, J., & Makino, H. (1998) · Diabetologia · doi:10.1007/s001250051088 · Cited by 161
Flyvbjerg, A., Bennett, W. F., Rasch, R., Kopchick, J. J., & Scarlett, J. A. (1999) · Diabetes · doi:10.2337/diabetes.48.2.377 · Cited by 158
Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy
Mathews, M. K., Merges, C., McLeod, D. S., & Lutty, G. A. (1998) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(99)80220-7 · Cited by 153
Simon, M., Röckl, W., Hornig, C., Gröne, E., Theis, H., Weich, H. A., Fuchs, E., Yayon, A., & Gröne, H. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v961032 · Cited by 141
The impact of experimental diabetes mellitus in rats on glomerular capillary number and sizes
Nyengaard, J. R., & Rasch, R. (1993) · Diabetologia · doi:10.1007/bf00399948 · Cited by 140
Komers, R., Allen, T. J., & Cooper, M. E. (1994) · Diabetes · doi:10.2337/diab.43.10.1190 · Cited by 139
Sone, H., Kawakami, Y., Okuda, Y., Kondo, S., Hanatani, M., Suzuki, H., & Yamashita, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0568 · Cited by 118
Gruden, G., Thomas, S., Burt, D. J., ZHOU, W., Chusney, G. D., Gnudi, L., & Viberti, G. C. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v104730 · Cited by 108
Han, D. C., Hoffman, B. B., Hong, S. W., Guo, J., & Ziyadeh, F. N. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.278.4.f628 · Cited by 105
Growth Hormone Receptor Antagonism Prevents Early Renal in Nonobese Diabetic Mice
Segev, Y., Landau, D., Rasch, R., Flyvbjerg, A., & Phillip, M. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v10112374 · Cited by 68
Jensen, T. J. (1997) · Diabetes · doi:10.2337/diab.46.2.s98 · Cited by 55
Determination of Glomerular Filtration Rate in Rats
K�hnle, H. F., Linzmeier, P., & Doerge, L. (2015) · KARGER eBooks · doi:10.1159/000421117 · Cited by 7
Cited by
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
The pathogenesis of diabetic nephropathy
Dronavalli, S., Duka, I., & Bakris, G. L. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0894 · Cited by 625
From the Periphery of the Glomerular Capillary Wall Toward the Center of Disease
Wolf, G., Chen, S., & Ziyadeh, F. N. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1626 · Cited by 565
The role of vascular endothelial growth factor (VEGF) in renal pathophysiology
Schrijvers, B. F., Flyvbjerg, A., & De Vriese, A. S. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00621.x · Cited by 504
Self-citationPossible molecular mechanisms involved in the toxicity of angiogenesis inhibition
Verheul, H. M. W., & Pinedo, H. M. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2152 · Cited by 503
Metadata
- Authors
- DE VRIESE, A. S., TILTON, R. G., ELGER, M., STEPHAN, C. C., KRIZ, W., & LAMEIRE, N. H.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2001-05
- Volume
- 12
- Issue
- 5
- Pages
- 993-1000
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2101417448
- Cited by
- 442
- References
- 36
- FWCI
- 15.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.